Kristina Burow - Director, 10%+ Owner at Neumora Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Issuer Symbol
NMRA on Nasdaq
All Insider Reports
All Insider Reports

Kristina Burow - trading volume in the past year for Neumora Therapeutics, Inc.

Holdings reported by Kristina Burow for Neumora Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 12,205,379 $22,213,789 $1.82 27 Oct 2025 By ARCH Venture Fund X, L.P.
Common Stock 11,886,758 $21,633,899 $1.82 27 Oct 2025 By ARCH Venture Fund X Overage, L.P.
Common Stock 6,046,907 $15,782,427 $2.61 27 Oct 2025 By ARCH Venture Fund XII, L.P.
Common Stock 2,321,566 $4,225,250 $1.82 27 Oct 2025 By ARCH Venture Fund VIII Overage, L.P.
Common Stock 1,387,228 $2,524,754 $1.82 27 Oct 2025 By ARCH Venture Fund VII, L.P.
Common Stock 47,717 $86,844 $1.82 27 Oct 2025 Direct
Stock Option (Right to Buy) 80,000 28 May 2025 Direct Common Stock

Transactions reported by Kristina Burow for Neumora Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.